‘Rock Weekly’ Category

Rock Weekly: Healthcare still a sad place for diversity

| March 24, 2015|Tags:

Rock Weekly

March 23, 2015

We’re thrilled to announce our latest investment, Collective Health, which just picked up $38M to bring much-needed modernization to employer-sponsored health insurance. Here’s why we’re finally excited about getting coverage from employers.

In addition to funding remarkable companies, we’re also committed to promoting diversity in the industry. Despite making up 78% of healthcare’s workforce, women represent only 6% of CEOs of funded digital health companies and 21% of the C-suite of Fortune 500 healthcare companies. We can do better. Read more in our just-released, third annual State of Women in Healthcare report.

Rock Weekly: Apple:breadth as Google:depth

| March 16, 2015|Tags:

Rock Weekly

March 16, 2015

In less than 24 hours, Apple’s new ResearchKit did what would take 50 medical centers a whole year to do in traditional trials, albeit with some bias toward the rich and healthy. The platform is the latest example of the shifting center of care—but Apple isn’t the only tech giant tackling clinical data, they’re just prioritizing breadth by embracing open-source.

We are too. Join us for our free webinar on The State of Women in Healthcare on March 25th at 10am PT.

Rock Weekly: 17 can’t-miss things at SXSW

| March 09, 2015|Tags:


March 9, 2015

Last week we announced two of our latest investments. Meet Chrono Therapeutics, a digital therapy company that combines smart drug delivery with behavioral medicine software to help people quit smoking—and Evidation Health, a company born out of GE, Stanford, and The Activity Exchange that measures the real-world effectiveness of these exact types of digital health products.

Fancy yourself some digital health events soon? Here’s 17 can’t-miss events for health nerds at SXSW next week and everything you need to know about interoperability—at our office on 3/19.

Rock Weekly: Unintended consequences of digital health

| March 02, 2015|Tags:

Rock Weekly

March 2, 2015

We’re (obviously) over the moon about the growing popularity of digital health—but unintended consequences grow alongside innovation. For one, as the line between patient and consumer gets blurred, so do the regulatory roles of the FDA and theFTC. And let’s not ignore the fact that medical identity theft has risen sharply. We love that healthcare is becoming increasingly digital, but let’s proceed with caution.

What else do we love? Our readers. Here’s 50 free (and sold-out) passes to Launch Festival, which takes over San Francisco this week.

Rock Weekly: The FDA approval you’ve been waiting for

| February 23, 2015|Tags:


February 23, 2015

Last week the FDA gave our friends at 23andMe a big green light to market genetic testing for one specific disease—and announced plans to re-classify similar tests moving forward.

If the FDA is affecting your mental health, we have a solution. Lantern offers personalized programs for diverse mental health issues, combining quick daily exercises with professional coaching. Try a free assessment. Then use the codeRH10 for 10% off your first month (for the first 50 readers).


Rock Weekly: How healthcare reform fuels digital health

| February 16, 2015|Tags:


February 16, 2015

A huge chunk of the 125% growth in digital health funding has flowed to companies embracing new healthcare reform-fueled business models. From telemedicine to consumer engagement and HITECH to HealthKit, become an expert with our series about how healthcare legislation is shaping the digital health landscape.

Rock Weekly: Hackers love healthcare

| February 09, 2015|Tags:

Rock Weekly

February 9, 2015

“Every smart tech person I know is working in healthcare,” said legendary investor John Doerr at our CEO Summit last week. Healthcare is hot—and clearly so is (stealing) health data, helped by the fact that the industry’s cybersecurity lags far behind other sectors (which the FBI warned of last April).

23andMe Co-founder and CEO Anne Wojcicki onstage with This Week in Startups host Jason Calacanis at our Digital Health CEO Summit

Rock Weekly: Is HIPAA good enough?

| February 02, 2015|Tags:


February 2, 2015

POTUS praised EMRs, wearables, and data for their impact on the future of medicine, and called on entrepreneurs (and investors) to create tools for patients as part of the newly-unveiled Precision Medicine Initiative. Needless to say, sharing genetic data is pretty key to the whole project. Conveniently, the FTC just said it thinks HIPAA isn’t good enough to protect patient data.

Rock Weekly: Where’s the exit?

| January 26, 2015|Tags:

Rock Weekly

January 26, 2015

While digital health may be lagging on the public market, conversations about the industry dominated Inside the Beltway last week. POTUS kicked everything off by announcing the Precision Medicine Initiative (more on what it needs to actually work here), while the ONC declared it would better help entrepreneurs navigate HIPAA compliance. (FYI, these companies can too.)

Rock Weekly: Are wearables getting creepy?

| January 12, 2015|Tags:

January 12, 2015

The deluge of CES wearable and health device debuts has come to a close, and discussions were apparently “much more grounded” this year. Marc Benioff said wearable data is “heading to creepy” and the FTC chairwoman expressed concern about privacy in the era of connected devices. But as it turns out, most Americans are just fine sharing their health data for research—and companies are taking them up on it.

We have two big pieces of news from our portfolio companies today! Hot off tracking 3.5M medications at 140 hospitals last year, Kit Check just raised $12M. And Augmedix raised $16M to help doctors do what they do best: take care of patients. Learn more about the Rock Health portfolio.